Optum is closing its adult medical care office on 10th Street in Secaucus on April 7. Optum's pediatric office at 10th Street ...

The largest NLRB union election win in February was at the primary care group Optum Care, a subsidiary of UnitedHealthcare.

Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...

In a statement, Optum said that the efforts have been made on a variety of fronts to improve services for patients. “Since these practices chose to join Optum, we have introduced a number of new ...

The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark ...

Vertex's Journavx, a new non-opioid pain drug, lands Tier 3 on Optum Rx formularies. Vertex reports $2.91 billion Q4 sales.

In this episode, Dr. Ken Cohen, Executive Director of Translational Research at Optum Health, discusses the impact of value-based care models on patient outcomes. He shares key findings from his ...

These changes are part of ongoing efforts to reduce total UnitedHealthcare prior authorization volume," the company said.

Vertex Pharmaceuticals’ (VRTX) non-opioid pain drug Journavx was picked up by UnitedHealth’s (UNH) Optum on “Tier 3.” The insurer said, ...

Optum Rx, a pharmacy benefit manager owned by one of the country’s largest insurance companies, UnitedHealth Group, has added a new, much-anticipated pain drug to some of its commercial ...